SMi MASTERCLASS on Practical Risk Minimisation of Drugs in Europe
hosted by Head of OXON, Dr Nawab Qizilbash
Nawab Qizilbash, Head of OXON and Joint Coordinator of the ENCePP Special Interest Group on Impact of PV Activities, will lead an interactive masterclass on Practical Minimisation of Drugs in Europe.
4 July 2017, 08:30 - 17:30 (UK time)
This masterclass is relevant to drugs in phase III, drugs at the approval stage and newly approved and generic drugs with new safety issues requiring additional risk minimisation measures.
Attendees will learn about expectations of EU regulators, how to identify, develop, implement and evaluate risk minimisation measures. Read more